Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000612273 | SCV000710924 | uncertain significance | not specified | 2016-08-23 | criteria provided, single submitter | clinical testing | The c.774-14G>T variant in RYR2 has not been previously reported in individuals with cardiomyopathy but has been identified in 6/9594 African chromosomes by th e Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs37 0114411). This variant is located in the 3' splice region. Computational tools p redict some impact to splicing. However, this information is not predictive enou gh to determine pathogenicity. In summary, the clinical significance of the c.77 4-14G>T variant is uncertain. |
Gene |
RCV000828505 | SCV000970197 | likely benign | not provided | 2018-05-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001189433 | SCV001356721 | likely benign | Cardiomyopathy | 2018-12-18 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000828505 | SCV001471876 | likely benign | not provided | 2020-03-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002531122 | SCV002404322 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-01-10 | criteria provided, single submitter | clinical testing |